Ampio Pharmaceuticals to Acquire DMI Bioscie... (this time disclose the licensee for the ...)

Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.

Date:4/22/2010

this time disclose the licensee for the drug that is executing the Phase III trial. The acquisition of the P.E. drug by AMPIO enhances our portfolio of drugs that currently focus on alleviating diabetic and inflammatory conditions."

About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc. develops drugs to treat metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The company's product pipeline includes certain FDA approved drugs, now targeted at new clinical indications protected by Ampio intellectual property, and new molecular entities ("NMEs"). The company's development of new uses for previously approved drugs is expected to result in reduced approval timelines, lower costs and decreased risks of clinical failure. The company is actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's near term and long term product development programs.

Safe Harbor Statement

This press release may contain forward-looking statements that involve risks and uncertainties, such as statements of Ampio's plans, objectives, expectations and intentions. Forward-looking statements are generally identified by words, such as "projects," "believes," "anticipates," "plans," "expects," "will," and "would," and similar expressions that are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause the actual results, performance or achievements of Ampio to be materially different from those expressed or implied by forward-looking statements. Actual events may differ materially from those mentioned in these forward-looking statements because of a number of risks and uncertainties. A discussion of factors affecting Ampio's business and prospects is contained in Ampio's periodic filings with
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
2. Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
3. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
4. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
5. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
6. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations
10. Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market
11. Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding

Post Your Comments:

(Date:5/17/2013)... Mass. , May 17, 2013 Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...

(Date:5/16/2013)... Therapeutics, (Nasdaq: NKTR ) President and Chief Executive ... to present at the upcoming 2013 UBS Global Healthcare Conference ... New York Hotel on Tuesday, May 21, 2013 at 10:00 ... via a Webcast through a link posted in the Investor ... . This Webcast will be available for replay until June ...

(Date:5/16/2013)... OAKS, Calif. , May 16, 2013 Amgen (NASDAQ: ... Life Sciences Conference on Tuesday, May 21, 2013, at the ... City , beginning at 10:00 a.m. Eastern Daylight Time. ... vice president of Research and Development at Amgen, will present ... accessed from the Events Calendar on Amgen,s website, www.amgen.com ...

Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2

[0] Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 [0] Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City [0] Amgen To Present At The UBS Global Life Sciences Conference

... Md., Aug. 1, 2011 /PRNewswire-USNewswire/ – CoMeD ... Nations Environment Programme (UNEP) distributed a revised ... Advocates for mercury-free drugs were gratified to see pharmaceuticals ... the proposed treaty. The Coalition for ...

... 2011 Reportlinker.com announces that a new ... catalogue: Patient Self-Monitoring: Devices, ... http://www.reportlinker.com/p0581171/Patient-Self-Monitoring-Devices-Markets-Players-and-Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... monitor their own serum levels is deemed ...

Cached Medicine Technology:Global Mercury Treaty May Include Ban on Mercury in Medicine 2 Global Mercury Treaty May Include Ban on Mercury in Medicine 3 Patient Self-Monitoring: Devices, Markets, Players and Prospects 2 Patient Self-Monitoring: Devices, Markets, Players and Prospects 3

Global Mercury Treaty May Include Ban on Mercury in Medicine Patient Self-Monitoring: Devices, Markets, Players and Prospects

(Date:5/19/2013)... (PRWEB) May 20, 2013 Due to ... with online advertising, MileageAds.com has decided to invite bloggers ... through their ad network. , Businesses in the ... success with online marketing, specifically with ad networks. ... information and legal services and are unsure where to ...

(Date:5/19/2013)... physicians are key decisionmakers for nearly half of all ... in reducing health care costs, according to a new ... admissions from the ER increased by 17 percent over ... hospital admissions between 2003 and 2009. Hospital inpatient ... accounting for 31 percent of the nation,s health care ...

(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... tickets for his two concerts in Vegas in October ... 20th. Additionaly, during the spring and summer months of ... the country. , Whenever people hear “It’s Five ... and hear the voice of Jimmy Buffett inside their heads. ...

(Date:5/19/2013)... (PRWEB) May 19, 2013 Daily Gossip reporters ... 17 Cheat Foods That Burn Fat to a ... readers. , The review is a detailed ... by the writer's recommendation. , The two nutritionists have discovered ... is responsible for the caloric intake and expenditure of our ...

(Date:5/19/2013)... May is officially known as Skin Cancer Awareness ... Australia, the country's forerunner in fashionable children’s sun ... to kick off their month long mission to bring ... staggering number of cancer cases diagnosed each year, the ... out what’s causing the epidemic and how to stop ...

Breaking Medicine News(10 mins):Health News:Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network 2 Health News:ER docs are key to reducing health care costs 2 Health News:ER docs are key to reducing health care costs 3 Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 2 Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 3 Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2 Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 2 Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 3

[0] Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network [0] ER docs are key to reducing health care costs [0] Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time [0] The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip [0] Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents

... , ... ... ... ...

... ... ... , ... , , ...

... , ... ... , , , , ... ...

... can have strokes, and the strokes can recur, usually ... strokes often go unrecognized the first time, and the ... Pediatric neurologist Rebecca Ichord, M.D., director of the Pediatric ... today on a study of arterial ischemic stroke in ...

... ... previously unrecognized set of targets and biomarkers to battle solid tumors. , ... (Vocus) February 24, 2010 -- Cancer ... to battle solid tumors. , , , , ,The findings center on discovery of ...

... , ... ... ... ...

Kendle Announces Fourth Quarter and Full-Year 2009 Results The Hub, LLC Announces Strategic Acquisition of EIM Corporation Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field Children can have recurrent strokes New Cancer-Fighting Strategy Focuses On Signaling Molecules China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank

When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator. , ,Most Appropriate for the Proximal Femur, Metatarsal/Tar...

... Pulsed ElectroMagnetic Field (PEMF) bone growth stimulation ... option for long bone and small bone ... cast, orthopedic brace, or clothing without lessening ... in one compact, lightweight unit including success ...

Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....

... Cannulated Interference Screws. Optimal ... and graft selection options. ... without deformation, and chamfered ... threaded atraumatic tissue fixation. ...

Medicine Products:

BioElectron Orthopak Physio-Stim Bone Growth Stimulator Interference Screws ABSOLUTE Absorbable Cannulated Interference Screws